Completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +44 more Locations Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer NCT01010126 Conditions Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more Locations Mayo Clinic in Arizona — Scottsdale, Arizona, United States Tower Cancer Research Foundation — Beverly Hills, California, United States City of Hope Comprehensive Cancer Center — Duarte, California, United States Los Angeles County-USC Medical Center — Los Angeles, California, United States View all 61 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma NCT01204476 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors NCT01841736 Conditions Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1, +11 more Locations Alaska Breast Care and Surgery LLC — Anchorage, Alaska, United States Alaska Women's Cancer Care — Anchorage, Alaska, United States Anchorage Oncology Centre — Anchorage, Alaska, United States Katmai Oncology Group — Anchorage, Alaska, United States View all 423 locations View more locations Show fewer locations Loading locations... View Trial Details
